Carbon insurer Kita explores 'brand new market for the insurance industry'

Kita

Appointing itself the 'world's first carbon insurer', nascent Lloyd’s Lab start-up Kita is aiming for managing general agent status within the year and hopes to start insuring carbon reduction and removal products by early 2023.

Currently based within Lloyd’s Lab, the start-up recently raised £350k in a pre-seed round led by Insurtech Gateway, alongside investors Carbon13, Climate VC and Echelon Capital.

Named for the

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Register

Want to know what’s included in our free registration? Click here

Already have an account? Sign in here

Big Interview: Steve Tooze, Extinction Rebellion

Steve Tooze, spokesperson for climate pressure group Extinction Rebellion, tells Damisola Sulaiman about the group’s motivations for targeting the insurance industry, responds to questions from the companies his organisation has targeted and shares plans for direct action in 2025.

What insurers should do to stop sexual harassment

Analysis: Damisola Sulaiman reviews the progress of trade bodies in responding to the Financial Conduct Authority’s findings on sexual harassment in the industry and explores what steps insurers and brokers can take to prevent abusive incidents and the ramifications if they fail to do so.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here